VeriMom¿Es human neonatal fibroblast/keratinocyte conditioned media seguro durante el embarazo?
No harmonised CLP classification, no CIR or SCCS safety assessment, and no peer‑reviewed reproductive or developmental toxicity data specifically implicating human neonatal fibroblast/keratinocyte conditioned media. The material is a complex mixture of native human proteins/growth factors; large proteins have low dermal bioavailability, so topical exposure is expected to be negligible. (Sources consulted: ECHA Annex VI (no entry), CIR (no assessment), PubMed (no reproductive toxicity reports)).
Related ingredients
Frequently asked questions
- ¿Es human neonatal fibroblast/keratinocyte conditioned media seguro durante el embarazo?
- No harmonised CLP classification, no CIR or SCCS safety assessment, and no peer‑reviewed reproductive or developmental toxicity data specifically implicating human neonatal fibroblast/keratinocyte conditioned media. The material is a complex mixture of native human proteins/growth factors; large proteins have low dermal bioavailability, so topical exposure is expected to be negligible. (Sources consulted: ECHA Annex VI (no entry), CIR (no assessment), PubMed (no reproductive toxicity reports)).
- ¿Es human neonatal fibroblast/keratinocyte conditioned media seguro durante la lactancia?
- No evidence of reproductive or lactation-specific hazard in authoritative sources. Proteins in conditioned media are unlikely to be systemically absorbed in relevant amounts after topical use; therefore breast milk exposure is expected to be negligible absent systemic uptake. (Sources: CIR, PubMed, ECHA Annex VI — no classifications or assessments found).
- ¿Es human neonatal fibroblast/keratinocyte conditioned media seguro para la piel del bebé?
- No data indicating reproductive/developmental hazard for infants. Mechanistic concerns are theoretical only and not supported by data. Because infant skin (0–3 yr) has an immature barrier and higher surface‑area‑to‑weight, a small increase in potential exposure is prudent (adult exposure judged negligible → baby exposure scored +1). No infant‑specific absorption or toxicity studies were identified. (Sources: PubMed (no infant toxicology data), ECHA Annex VI (no entry), CIR (no assessment)).
- ¿Cómo puntúa VeriMom a human neonatal fibroblast/keratinocyte conditioned media?
- VeriMom puntúa human neonatal fibroblast/keratinocyte conditioned media en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a human neonatal fibroblast/keratinocyte conditioned media en el embarazo?
- Consulta nuestra lista de alternativas seguras a human neonatal fibroblast/keratinocyte conditioned media según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.